These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Acute myelogenous leukemia: a disorder of gene splicing? van der Reijden BA; van Ommen GJ; Hagemeijer A; Breuning MH Leukemia; 1996 Feb; 10(2):204-6. PubMed ID: 8637227 [TBL] [Abstract][Full Text] [Related]
23. BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML. Yoon JH; Kim HJ; Shin SH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Lim JH Eur J Haematol; 2013 Aug; 91(2):112-21. PubMed ID: 23672350 [TBL] [Abstract][Full Text] [Related]
24. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias. Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432 [TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of c-KIT mutations in core binding factor acute myeloid leukemia. Park SH; Chi HS; Min SK; Park BG; Jang S; Park CJ Leuk Res; 2011 Oct; 35(10):1376-83. PubMed ID: 21715005 [TBL] [Abstract][Full Text] [Related]
26. Core-binding factor acute myeloid leukemia: can we improve on HiDAC consolidation? Paschka P; Döhner K Hematology Am Soc Hematol Educ Program; 2013; 2013():209-19. PubMed ID: 24319183 [TBL] [Abstract][Full Text] [Related]
31. t(9;22) as secondary alteration in core-binding factor de novo acute myeloid leukemia. Vitale C; Lu X; Abderrahman B; Takahashi K; Ravandi F; Jabbour E Am J Hematol; 2015 Nov; 90(11):E211-2. PubMed ID: 26257212 [No Abstract] [Full Text] [Related]
32. Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia. Hsiao HH; Liu YC; Wang HC; Tsai YF; Wu CH; Cho SF; Hsu JF; Huang CT; Hsiao SY; Lee CP; Chang CS; Lin SF; Liu TC Genet Mol Res; 2015 Dec; 14(4):17028-33. PubMed ID: 26681050 [TBL] [Abstract][Full Text] [Related]
33. Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemias. Jones D; Yao H; Romans A; Dando C; Pierce S; Borthakur G; Hamilton A; Bueso-Ramos C; Ravandi F; Garcia-Manero G; Kantarjian H Genes Chromosomes Cancer; 2010 Feb; 49(2):182-91. PubMed ID: 19908318 [TBL] [Abstract][Full Text] [Related]
34. Minimal residual disease eradication with epigenetic therapy in core binding factor acute myeloid leukemia. Ragon BK; Daver N; Garcia-Manero G; Ravandi F; Cortes J; Kadia T; Oran B; Ohanian M; Ferrajoli A; Pemmaraju N; Kantarjian HM; Borthakur G Am J Hematol; 2017 Sep; 92(9):845-850. PubMed ID: 28494506 [TBL] [Abstract][Full Text] [Related]
35. A genome-wide single-nucleotide polymorphism-array can improve the prognostic stratification of the core binding factor acute myeloid leukemia. Huh J; Kim HJ; Jung CW; Kim HJ; Kim SH; Kim YK; Kim HJ; Shin MG; Moon JH; Sohn SK; Kim SH; Lee WS; Won JH; Mun YC; Kim H; Park J; Min WS; Kim DH; Am J Hematol; 2012 Oct; 87(10):961-8. PubMed ID: 22886749 [TBL] [Abstract][Full Text] [Related]
36. Acute promyelocytic leukemia relapsing as secondary acute myelogenous leukemia with translocation t(3;21)(q26;q22) and RUNX1-MDS1-EVI1 fusion transcript. Park TS; Choi JR; Yoon SH; Song J; Kim J; Kim SJ; Kwon O; Min YH Cancer Genet Cytogenet; 2008 Dec; 187(2):61-73. PubMed ID: 19027486 [TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and prognostic factors analysis of core binding factor acute myeloid leukemia in real world. Zhai Y; Wang Q; Ji L; Ren H; Dong Y; Yang F; Yin Y; Liang Z; Wang Q; Liu W; Mei Y; Zhang L; Li Y Cancer Med; 2023 Dec; 12(24):21592-21604. PubMed ID: 38062912 [TBL] [Abstract][Full Text] [Related]
38. High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities. Gröschel S; Lugthart S; Schlenk RF; Valk PJ; Eiwen K; Goudswaard C; van Putten WJ; Kayser S; Verdonck LF; Lübbert M; Ossenkoppele GJ; Germing U; Schmidt-Wolf I; Schlegelberger B; Krauter J; Ganser A; Döhner H; Löwenberg B; Döhner K; Delwel R J Clin Oncol; 2010 Apr; 28(12):2101-7. PubMed ID: 20308656 [TBL] [Abstract][Full Text] [Related]